öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÓྦྷ²¨
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º460

ËùÊôԺУ£ºÄþ²¨´óѧ
ËùÊôԺϵ£ºÒ½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÄÚ¿Æѧ
Ñо¿ÁìÓò£º ÀÏÄêҽѧ/¹ÇÖÊÊèËÉ
Ñо¿ÁìÓò£º ÀÏÄêҽѧ/¹ÇÖÊÊèËÉ [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºyujingbo@medmail.com.cn
ͨѶµØÖ·£ºÄþ²¨ÊеÚÒ»Ò½ÔºÐÐÕþÂ¥502


¸öÈ˼òÊö :


ÏÖÈÎÄþ²¨ÊеÚÒ»Ò½Ôº¸±Ôº³¤£¬ÐÄÄÚ¿ÆÖ÷ÈÎҽʦ¡£µ£ÈÎÄþ²¨ÊÐÖصãѧ¿ÆÀÏÄêҽѧѧ¿Æ´øÍ·ÈË£¬Õã½­´óѧҽѧԺ˶ʿÉúµ¼Ê¦£¬Äþ²¨´óѧÄÚ¿Æѧ¼æÖ°½ÌÊÚ£¬ÖйúÀÏÄêҽѧѧ»áÀíÊ£¬Õ㽭ʡҽѧ»áÀÏÄêҽѧ·Ö»á¸±Ö÷ÈÎίԱ£¬Õã½­Ê¡¸ßѪѹԤ·ÀÓë¿ØÖÆöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±Ö÷ÈÎίԱ£¬Õã½­Ê¡ÖÐÎ÷Ò½½áºÏѧ»áÀÏÄ겡·Ö»á¸±Ö÷ί£¬Õã½­Ê¡ÀÏÄêѧ»áÀÏÄ겡·Ö»á¸±»á³¤£¬Äþ²¨Ò½Ñ§»áÀÏÄ겡ѧ·Ö»áÖ÷ÈÎίԱ£¬Äþ²¨Ò½Ñ§»á¹ÇÖÊÊèËɺ͹ǿóÑηֻḱÖ÷ί£»´ÓÊÂÐÄѪ¹ÜÄڿƼ°ÀÏÄêҽѧÁÙ´²30Ä꣬Éó¤¸÷ÖÖ¸ßѪѹ¡¢ÐÄÂÉʧ³£¡¢¹ÚÐIJ¡¡¢ÐÄÔàÆ𲫵ÈÐÄѪ¹Ü³£¼û²¡¼°ÒÉÄÑ¡¢ÖØΣ²¡µÄÕïÖΣ¬Ô­·¢¡¢¼Ì·¢¹ÇÖÊÊèËÉÑо¿¼°¸÷ÖÖÀÏÄ겡µÄÕïÖΡ£


¿ÆÑй¤×÷ :
·¢±íSCIºÍÖлªÏµÁÐÂÛÎÄ16ƪ

½üÆÚÂÛÎÄ£º
1.ABCB1 C3435T polymorphism and the lipid-lowering response in hypercholesterolemic patients on statins:a meta-analysis

IF 2.219
2.No causal effect of serum urate on bone-related outcomes among a population of postmenopausal woman and elderly men of Chinese Han ethnicity--a Mendelian randomization study. IF 4.169
3.Sleep duration and total cancer mortailty: a meta-analysis of prospective studies. IF 3.339
4.The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population. IF 3.234
½üÆÚÖø×÷

1.¡¶¼±Õïҽʦ¹æ·¶Êֲᡷ ÈËÃñÎÀÉú³ö°æÉç

ÖйúÀÏÄêҽѧѧ»áÀíÊÂ

Õ㽭ʡҽѧ»áÀÏÄêҽѧ·Ö»á¸±Ö÷ÈÎίԱ

Õã½­Ê¡¸ßѪѹԤ·ÀÓë¿ØÖÆöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±Ö÷ÈÎίԱ

Õã½­Ê¡ÖÐÎ÷Ò½½áºÏѧ»áÀÏÄ겡·Ö»á¸±Ö÷ί

Õã½­Ê¡ÀÏÄêѧ»áÀÏÄ겡·Ö»á¸±»á³¤

Äþ²¨Ò½Ñ§»áÀÏÄ겡ѧ·Ö»áÖ÷ÈÎίԱ

Äþ²¨Ò½Ñ§»á¹ÇÖÊÊèËɺ͹ǿóÑηֻḱÖ÷ί

³Ðµ£7ÏîÊ¡¡¢Êм¶¿ÎÌâÑо¿£¬ÆäÖÐÖ÷³ÖÄþ²¨ÊпƼ¼¼Æ»®ÏîÄ¿2ÏÔÚÑÐ1Ï

2007-2009Ö÷³ÖÊ¡ÎÀÉú¿ÆÑлù½ðÏîÄ¿¡¶ÀÏÄêÈËÌåÖ¬·Ö²¼Óë¹ÇÃܶȵĹØϵÑо¿¡·£¬»ñÄþ²¨ÊÐ×ÔÈ»¿ÆѧÓÅÐãÂÛÎÄÈýµÈ½±¡£